• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio

    Frontage Bolsters Clinical Services Capabilities

    Sanofi Unveils EUROAPI as Name of New European API Company

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza

    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

    LSNE Expands Fill Finish and Lyophilization Ops
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Virtual Clinical Trials: The Future of Dermatology Studies

    Frontage Bolsters Clinical Services Capabilities

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics

    The Wasdell Group Earns ISO 13485 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Syngene

    Baxter BioPharma Solutions

    Adare Pharma Solutions

    PCI Pharma Services

    Alcami
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    PCI Pharma Services

    Baxter BioPharma Solutions

    Adare Pharma Solutions

    Flow Sciences

    Cytovance Biologics
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Stripping Serialization Back to Data Integrity

    Why companies can’t afford to make compromises on quality

    Stripping Serialization Back to Data Integrity
    Related CONTENT
    • Samsung Biologics Continues to Leverage Digitalization to Optimize Client Experience
    • UK’s VMIC to Implement Lonza’s MODA-EM
    • Samsung Biologics Breaks Ground on 'Super Plant'
    • Bye-Bye China?
    • CDMO QCL Expands Fill Finish Capabilities
    Rachna Mohanka, Sr. Director, Global Solution Consulting, TraceLink05.08.18
    Serialization remains the pharma industry’s biggest challenge, it is a complex creature with a vast number of stakeholders, regulatory requirements and investment needs, however, many industry players are failing to see the forest for the trees. While fast-approaching (and recently passed in some instances) deadlines are driving many of the decisions being made, it is easy to forget that the need for high quality data that demonstrates product legitimacy is what has driven the development of serialization mandates in more than 50 countries.

    Since 2016, a number of the world’s leading regulatory agencies including; the TGA in Australia, FDA in the U.S., MHRA in the UK; European Medicines Agency (EMA); World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme have issued guidance documents that detail GxP data integrity and governance expectations. All the agencies highlight the importance of a holistic approach to ensuring data integrity irrespective of internal processes; if they guarantee complete and accurate records then the internal process is deemed compliant.

    This article explores the role of data integrity in serialization programs and the key considerations for pharmaceutical companies in identifying data integrity inefficiencies. It will also offer some guidance on how these challenges can be overcome through effective planning and implementation.

    The role of data integrity in serialization
    Data integrity is essentially a constant effort to prevent errors in data management that hide test failures, logistical errors and/or manufacturing deviations because of; errors in recording destruction, omission, changes and deletions. 

    Given the current climate where global serialization mandates are so high on the agenda, it is imperative that pharma businesses pay close attention to their data integrity processes.
    The entire serialization effort and its principles assume that data is being recorded, stored and transferred correctly—if the data isn’t correct in its most fundamental form then serialization efforts are in vain. 

    Data management requirements from DSCSA
    The FDA has set very broad parameters when it comes to current good manufacturing practice (cGMP) data management requirements:
    “FDA expects that data be reliable and regulations and guidance allow for flexible and risk-based strategies to prevent and detect data integrity issues. Firms should implement meaningful and effective strategies to manage their data integrity risks based upon their process understanding and knowledge management of technologies and business models.”

    The guidance offers little in the way of specifics, giving the pharma industry quite a bit of autonomy to implement its own standards and processes—importantly, these could quite easily exceed the FDA’s expectations. At this point in the implementation of the Drug Supply Chain Security Act (DSCSA), a standard data format has not been decided by the FDA, but it will be essential on a practical level if data is to be easily shared among numerous supply chain partners. Also, there is no agreement in place on how the data and databases will be managed. In the distributed U.S. model, each organization stores and transmits its own data as required.

    What the industry does know however is what it will need to do with data to meet the DSCSA regulations. Pharma businesses through the entire supply chain will need to manage serial number requests and responses with the different packaging line systems they and their supply partners work with. Commissioning events must be captured, and data exchanges managed as a product travels from a packing line through to the final dispensing environment. Downstream, businesses will have to develop a means of sending aggregation data and responding to verification inquiries from anyone that has a product in their possession.

    Challenges in sustaining data integrity
    The end-to-end serialization approach in the U.S. has created a network where data travels seamlessly between every stakeholder within a supply chain and creates a comprehensive record (or data chain) for the medicine throughout the process. In principle, it’s a very robust approach that aims to prevent counterfeiting by identifying perpetrators and weak links in the supply chain, however the challenge in sustaining data integrity is very much a human one. As the U.S. has adopted a full track and trace system, whenever there is change in ownership of a medicine at each point in the supply chain, the product and its certificate of authenticity must be verified alongside a certificate of sale, all of which is held in a repository system. While data records are digitized, their creation and input are still performed by people, leaving room for error that can only be partially resolved with comprehensive plans, training and regular self-inspection to ensure staff compliance and understanding of the requirements.

    The problem caused by the earlier mentioned lack of concrete guidance from the FDA when it comes to data format is that each link in the supply chain will potentially have their own preferences, capabilities or interpretations of the requirements which can impact how the serialization system is designed. At each data transfer point, there is a real risk of data being lost if the two systems don’t interface. While end-to-end cloud platform providers can provide a unified approach to their entire network, there is little chance that manufacturers et al. will exclusively deal with businesses within these networks.

    Key considerations for pharmaceutical companies
    While the FDA is yet to impose a standardized approach to data format, storage and management, it may do so in the future. This creates an extra pressure on pharma businesses in their push towards serialization as they not only need to implement a solution that meets currently understood regulatory requirements for data storage and exchange, but one that offers scalability and flexibility to meet these likely, new requirements at some time in the coming years.

    Importantly, this concern should be mooted by pharma’s globalization and the inherent need for flexibility when it comes to implementing serialization solutions that meet the requirements of other regulatory bodies and governments. While the ALCOA principles for data management have transcended borders, a lack of global standards when it comes to serialization muddies the waters and means that companies implementing serialization projects across multiple countries face growing complexity and cost.

    Meeting the challenges
    While the challenges are many, substantial and constantly evolving, they can be met. A full serialization set-up considers everything from site-level hardware, software and data storage to national and even global data transfer technology. It requires a comprehensive strategy that is tailored to individual needs. Businesses throughout the pharma industry should be adopting a clear data management plan and a solution that acknowledges and accommodates for diverse and mutable requirements as part of a global network. 
    The strategy requirements can be segmented in line with each level of serialization. If data management and transfer requirements aren’t met at every stage, then the entire process is flawed:
    • Level 1. Devices on packing lines that print, inspect, reject and handle materials must be able to perform the fundamental first step of serialization. It may mean that businesses need to invest in packing line hardware, but printing and ensuring codes are readable and accurate is a must as it underpins every step through the rest of the supply chain.
    • Level 2. Picking and packing line software that manages level 1 devices and supports device integration with site systems for conducting warehouse operations.
    • Level 3. Site level serialization software that allocates serial numbers to lines, verifies the integrity of information submitted to the enterprise system and performs changes to aggregation hierarchies and processing of shipments. This has traditionally been provided by individual line management system (LMS) vendors to work with their specific equipment, but LMS-agnostic site servers that can work with different line systems are beginning to emerge and are worth exploring.
    • Level 4. A global enterprise system enables management of all serialization and regulatory data and business processes. Provided by a serialization solution vendor, this is necessary to manage and verify the data that must accompany each serial number. When you begin serialization on the packaging line (Levels 1-3), you must at the same time determine how you will use and integrate the lines with your enterprise architecture.
    • Level 5. A global network enables management of all serialization and regulatory data between partners, customers, and regulatory authorities. This is provided by a serialization solution vendor with a global supply chain network. It’s vital that businesses consider their geographical reach and review the entire supply chain that their product flows through. It is important that businesses consider all the markets they operate in or might want to enter in the future and ensure they understand the various regulations to maintain compliance.
    To ensure continuous compliance and that the data is being managed effectively through each level, businesses must take a proactive approach and continuously test their processes by conducting self-inspections and audits.

    Staff at each level and at every stage of the supply chain must be trained to not only deliver their respective manufacturing, logistical or transactional role, they must also understand how their role fits into the wider supply chain and be able to identify problems with system interfaces and data transfer.

    Final thought
    Data integrity practices are the foundations of serialization success, they are also one of the longest standing problems in any industry that engages with and or manages the flow of information. The combined effect has meant that the serialization challenge has exponentially developed layers of complexity as businesses work towards meeting the DSCSA requirements, unearthing new system failings as they do.

    There is great solace however for pharma businesses as successful data integrity practices, and the wider serialization implementation, can be achieved through comprehensive planning and strategy development, supported by industry expertise from third-party vendors and underpinned by staff training and dedicated self-assessment.

    Data integrity and serialization will be discussed at FutureLink Munich, 5-7 June 2018, the annual global gathering of commercial and operational executives from the pharmaceutical and healthcare industries to discuss regulatory compliance with track and trace requirements and the future of digital drug supply with information sharing networks. For more information, please visit FutureLink Munich (www.tracelink.com/futurelink-munich/about). 


    Rachna Mohanka heads the global solutions consulting group at TraceLink and has been working on serialization and track and trace for over 4 years. In addition to pharma serialization and track and trace, her experience includes logistics, supply chain management, retail and ecommerce. Rachna has a master’s degree in supply chain from MIT and undergraduate in engineering from IIT Kanpur (India).
    Related Searches
    • training
    • events
    • supply chain
    • equipment
    Suggested For You
    Samsung Biologics Continues to Leverage Digitalization to Optimize Client Experience Samsung Biologics Continues to Leverage Digitalization to Optimize Client Experience
    UK’s VMIC to Implement Lonza’s MODA-EM UK’s VMIC to Implement Lonza’s MODA-EM
    Samsung Biologics Breaks Ground on Samsung Biologics Breaks Ground on 'Super Plant'
    Bye-Bye China? Bye-Bye China?
    CDMO QCL Expands Fill Finish Capabilities CDMO QCL Expands Fill Finish Capabilities
    Dr. Reddy Dr. Reddy's Goes Paperless with ValGenesis VLMS
    New GXP Data Integrity Guidance Published by MHRA New GXP Data Integrity Guidance Published by MHRA
    2018: The evolution of pharmaceutical packaging 2018: The evolution of pharmaceutical packaging
    Janssen Janssen's Supply Chain VP Talks Trends
    Bridge Therapeutics Appoints Finance Director Bridge Therapeutics Appoints Finance Director
    Drug Safety Update Drug Safety Update
    FDA’s Increased Information Transparency FDA’s Increased Information Transparency
    Ensuring Serialization Effectiveness Ensuring Serialization Effectiveness
    Biosyn Selects TraceLink to Align Regulations Biosyn Selects TraceLink to Align Regulations
    HHS 2019 Budget Proposal: Key Priorities Impacting Pharma HHS 2019 Budget Proposal: Key Priorities Impacting Pharma

    Related Features

    • Clinical Trials | Information Technology | R&D
      Decentralized Trials Fuel AI Revolution in Clinical Research

      Decentralized Trials Fuel AI Revolution in Clinical Research

      The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.
      Nick Moss, Vice President of Analytics and Machine Learning, Medable 11.17.20

    • Clinical Trials | Information Technology
      The Role of Electronic Monitoring in Maintaining Medication Adherence

      The Role of Electronic Monitoring in Maintaining Medication Adherence

      Digital solutions offer hope to get patients to take their medications properly.
      Bernard Vrijens, Scientific Lead, AARDEX Group 10.14.20

    • Information Technology
      You Need Solutions, Digitization is the Answer

      You Need Solutions, Digitization is the Answer

      Cloud technology helps today’s contract manufacturers be agile, transparent and efficient.
      Brian Curran, Senior Vice President of Strategic Growth, MasterControl 10.14.20


    • Information Technology
      Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI

      Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI

      The proven promise and huge potential of using AI and ML to accelerate drug discovery.
      Lucas Glass, Gary Shorter, and Rajneesh Patil, IQVIA 11.20.19

    • Information Technology
      A Brave New World of Data Integrity

      A Brave New World of Data Integrity

      How modern CMOs are keeping up with stringent regulatory guidelines by embracing advanced laboratory information systems.
      Bob Voelkner, VP Sales and Marketing, LabVantage 06.13.19

    • Clinical Trials | Information Technology
      The New Horizon: Metaprise Analytics in Life Sciences

      The New Horizon: Metaprise Analytics in Life Sciences

      Going beyond enterprise analytics to metaprise analytics—patient-centric systems that create a data driven trial team.
      Michelle Longmire, MD, CEO and Founder, Medable 05.07.19


    • Information Technology
      The Manufacturing Revolution In Medicine

      The Manufacturing Revolution In Medicine

      Real-time data insights help both pharma companies and contract manufacturers meet regulatory requirements while ensuring high production standards.
      Petter Moree, OSIsoft, LLC 05.07.19

    • Information Technology
      Industry 4.0 in the Pharma Industry

      Industry 4.0 in the Pharma Industry

      Digitization is not a single-handed project.
      Dr. Christian Hanisch, Project Manager Industry 4.0 Pharma, Bosch Packaging Technology 03.06.19

    • Information Technology
      Digitization: Pharma 4.0

      Digitization: Pharma 4.0

      A look at how technology is impacting the pharma industry
      Fatih Kaya and Gerald Buerkle, Vetter Pharma 01.25.19


    • Information Technology
      FDA & Data Integrity

      FDA & Data Integrity

      FDA Publishes Final Guidance on Data Integrity
      Robert Marohn, Director of Quality Business Systems, Kite Pharmaceutical 01.25.19

    • Information Technology | Serialization | Supply Chain
      Serialization Compliance

      Serialization Compliance

      Automated data controls during packaging help improve compliance.
      Miguel Pitarch, Executive Director, Global Serialization, Bristol-Myers Squibb & the Bristol-Myers Squibb Serialization Team 11.13.18

    • Clinical Trial Materials | Information Technology
      Interactive Response Technology in Clinical Trial Supply

      Interactive Response Technology in Clinical Trial Supply

      Exploring the benefits of including IRT professionals earlier in trial planning
      Dave Holly, Senior Manager, IRT Development and Operations, Sharp Clinical Services 10.10.18


    • Drug Development | Information Technology | R&D
      CRO Industry Update: Big Data Drives Drug Development Efforts

      CRO Industry Update: Big Data Drives Drug Development Efforts

      With growth in virtual trials and RWE, the clinical development landscape may never look the same
      Kristin Brooks, Managing Editor 05.11.18

    • Information Technology | Regulatory Affairs
      Data Integrity: A Practical  and Risk-Based Approach

      Data Integrity: A Practical and Risk-Based Approach

      Ways an organization can form a culture and cost-effective means to meet the various challenges in sustaining data integrity.
      Robert Marohn, ClinLogic, LLC 09.06.17

    • Drug Delivery | Fill/Finish | Information Technology | Lyophilization | Serialization | Supply Chain | Vials
      Packaging Equipment Close-Up

      Packaging Equipment Close-Up

      To meet the wide-ranging needs of the marketplace, suppliers and contract packagers are looking to deliver flexible solutions.
      Kristin Brooks, Contract Pharma 03.09.16

    Trending
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Roche Canada To Invest $500M To Create 500 Jobs In Ontario
    • Tonix And Fujifilm Enter COVID-19 Vax Deal
    • Sanofi Unveils EUROAPI As Name Of New European API Company
    • Sorrento, Mount Sinai To Develop COVI-Shield Antibody Therapy
    Breaking News
    • KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    • Frontage Bolsters Clinical Services Capabilities
    • Sanofi Unveils EUROAPI as Name of New European API Company
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Precision Medicine Group Acquires Project Farma
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Brown Fat Associated with Reductions in Chronic Disease Risk
    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    P&G, L'Oréal & Amorepacific Make News at CES
    Three Form Vertical Beauty Alliance
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login